Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stocks, par value $0,0001 per share
-
Shares outstanding
-
58.5M
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
25.3M
-
Shares change
-
+4.19M
-
Total reported value, excl. options
-
$746M
-
Value change
-
+$120M
-
Number of buys
-
57
-
Number of sells
-
-26
-
Price
-
$29.44
Significant Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q3 2021
92 filings reported holding BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share as of Q3 2021.
BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.3M shares
of 58.5M outstanding shares and own 43.27% of the company stock.
Largest 10 shareholders include FMR LLC (4.8M shares), Soleus Capital Management, L.P. (2.52M shares), WELLINGTON MANAGEMENT GROUP LLP (2.29M shares), VANGUARD GROUP INC (2.09M shares), Cormorant Asset Management, LP (1.82M shares), JANUS HENDERSON GROUP PLC (1.73M shares), BlackRock Inc. (1.27M shares), STATE STREET CORP (944K shares), PERCEPTIVE ADVISORS LLC (850K shares), and GREAT POINT PARTNERS LLC (844K shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.